small molecule

XTORO

FINAFLOXACIN

Loss of exclusivityNovember 2033latest FDA-listed patent expiry

CompanyFonseca →See this company's full patent-cliff portfolio

Drug detail

Brand name	XTORO
Active ingredient	FINAFLOXACIN
Strength	0.3%
Dosage form	SUSPENSION/DROPS
Route	OTIC
Modality	Small molecule
FDA approval	December 2014
Marketing status	RX

Listed patents

Patent	Expires	Type
9504691	November 2033	product
8536167	August 2031	use U-1679
9119859	July 2030	use U-1679
9993483	July 2030	product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.